Percutaneous Coronary Intervention Clinical Trials

6 recruiting

Frequently Asked Questions

Common questions about Percutaneous Coronary Intervention clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 18 of 8 trials

Recruiting

Cardio-Renal Registry

Myocardial InfarctionEnd Stage Renal DiseaseCerebrovascular Accident+3 more
Queen Mary University of London60,000 enrolled1 locationNCT06521801
Recruiting
Phase 2Phase 3

Remote Ischemic Preconditioning for Renal and Cardiac Protection in Congestive Heart Failure (RICH) Trial

Heart FailureAcute Kidney InjuryPercutaneous Coronary Intervention+2 more
VA Office of Research and Development240 enrolled3 locationsNCT04982419
Recruiting
Not Applicable

Temporary MCS With the iVAC 2L Transaortic Device in High-risk PCI

Cardiogenic ShockCoronary Artery DiseaseChronic Heart Failure+4 more
National Medical Research Center for Cardiology, Ministry of Health of Russian Federation100 enrolled1 locationNCT07149714
Recruiting
Phase 2

Improving Cardiac Rehabilitation Exercise Using Target Heart Rate Trial

Heart FailureMyocardial InfarctionCoronary Artery Bypass+2 more
Baystate Medical Center320 enrolled2 locationsNCT05925634
Recruiting
Not Applicable

LAAO Versus NOAC in Patients with AF and PCI

Atrial FibrillationPercutaneous Coronary Intervention
Xijing Hospital1,386 enrolled1 locationNCT05353140
Recruiting
Phase 4

Monotherapy With P2Y12 Inhibitors in Patients With Atrial fIbrillation Undergoing Supraflex Stent Implantation

Atrial Fibrillation (AF)Percutaneous Coronary Intervention (PCI)Oral Anticoagulation+1 more
Insel Gruppe AG, University Hospital Bern3,010 enrolled15 locationsNCT05955365
Recruiting

REgiStry-based Cardiovascular qUality improvEment Research

Heart FailureCardiometabolic SyndromePercutaneous Coronary Intervention+1 more
Peking University Third Hospital2,000 enrolled1 locationNCT06137885
Recruiting
Phase 4

Dual Antithrombotic Therapy With Dabigatran and Ticagrelor in Patients With ACS and Non-valvular AF Undergoing PCI

Atrial FibrillationAcute Coronary SyndromeAntithrombotic Therapy+1 more
Medical University of Gdansk2,230 enrolled1 locationNCT04695106